Manmeet Soni - May 15, 2023 Form 4 Insider Report for REATA PHARMACEUTICALS INC (RETA)

Role
COO, CFO and President
Signature
/s/ Tracy Herson, attorney-in-fact
Stock symbol
RETA
Transactions as of
May 15, 2023
Transactions value $
-$1,869,150
Form type
4
Date filed
5/17/2023, 04:39 PM
Previous filing
May 9, 2023
Next filing
Jun 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RETA Class A common stock Sale -$1.05M -12.4K -8.99% $84.32 126K May 15, 2023 Direct F1, F2
transaction RETA Class A common stock Sale -$752K -8.87K -7.04% $84.86 117K May 15, 2023 Direct F1, F3
transaction RETA Class A common stock Sale -$17.1K -200 -0.17% $85.64 117K May 15, 2023 Direct F1, F4
transaction RETA Class A common stock Sale -$50.6K -625 -0.54% $80.93 116K May 16, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this line represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $83.595 to $84.59 The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $84.595 to $85.545. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $85.635 to $85.65. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.